67 results on '"Ning, Yu-Ping"'
Search Results
2. NEFA can serve as good biological markers for the diagnosis of depression in adolescents
3. Mapping metabolite change in the mouse brain after esketamine injection by ambient mass spectrometry imaging and metabolomics
4. A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression
5. Elevated prelimbic cortex-to-basolateral amygdala circuit activity mediates comorbid anxiety-like behaviors in chronic pain
6. A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
7. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions
8. Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
9. Antianhedonic effects of serial intravenous subanaesthetic ketamine in anxious versus nonanxious depression
10. Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
11. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression
12. Adjunctive vagus nerve stimulation for treatment-resistant depression: a preliminary study
13. Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
14. An integrated machine learning framework for a discriminative analysis of schizophrenia using multi-biological data
15. Divergent Alterations of Structural–Functional Connectivity Couplings in First-episode and Chronic Schizophrenia Patients
16. Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
17. Multi-biological Classification for the Diagnosis of Schizophrenia Using Multi-classifier, Multi-feature Selection and Multi-cross Validation: an Integrated Machine Learning Framework Study
18. Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression
19. Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
20. Relationship between hippocampal volume and inflammatory markers following six infusions of ketamine in major depressive disorder
21. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression
22. Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply
23. Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis
24. Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression
25. A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression
26. Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials
27. Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic
28. Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy
29. Adjunctive folate for major mental disorders: A systematic review
30. A systematic review and combined meta‐analysis of concentration of oral amisulpride
31. Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies
32. Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
33. Sex Differences in the Prevalence and Clinical Features of Comorbid Depressive Symptoms in Never-Treated Chinese Patients With First-Episode Schizophrenia
34. Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis
35. Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies
36. Adjunctive minocycline for major mental disorders: A systematic review
37. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
38. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials
39. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
40. Sleep duration and self-rated health in Chinese university students
41. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials
42. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
43. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder
44. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
45. Self-Rating Functional Scale
46. The reliability and validity of a newly developed self-rating functional scale compared with Personal and Social Performance Scale and World Health Organization Disability Assessment Schedule II
47. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
48. Gender differences in the prevalence and clinical correlates of sleep disturbance in general hospital outpatients
49. Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics
50. Corrigendum to “Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials” [J. Psychiatr. Res. 103 (2018) 244-251]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.